Resonant Capital Advisors LLC Has $1.33 Million Holdings in Danaher Corporation $DHR

Resonant Capital Advisors LLC lessened its holdings in Danaher Corporation (NYSE:DHR) by 57.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,004 shares of the conglomerate’s stock after selling 9,396 shares during the period. Resonant Capital Advisors LLC’s holdings in Danaher were worth $1,331,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Bank Pictet & Cie Europe AG raised its holdings in Danaher by 25.4% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock worth $83,895,000 after purchasing an additional 74,301 shares during the last quarter. Maxi Investments CY Ltd bought a new position in shares of Danaher in the third quarter valued at $3,251,000. Defender Capital LLC. bought a new stake in Danaher during the 4th quarter worth approximately $35,715,000. Northwestern Mutual Wealth Management Co. grew its stake in shares of Danaher by 303.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after acquiring an additional 186,584 shares in the last quarter. Finally, CIBC Bancorp USA Inc. bought a new stake in shares of Danaher in the 3rd quarter worth $17,480,000. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Danaher stock opened at $194.17 on Wednesday. The firm has a market capitalization of $137.42 billion, a P/E ratio of 37.56, a PEG ratio of 2.47 and a beta of 0.79. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The business has a fifty day moving average price of $179.65 and a 200-day moving average price of $199.92.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same period in the previous year, the company posted $1.88 EPS. The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. As a group, equities research analysts forecast that Danaher Corporation will post 8.44 EPS for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is presently 30.95%.

Wall Street Analyst Weigh In

DHR has been the subject of several analyst reports. Wells Fargo & Company decreased their price objective on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 22nd. The Goldman Sachs Group cut their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Monday, April 13th. Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Rothschild & Co Redburn set a $205.00 price target on Danaher in a report on Friday, April 17th. Finally, Weiss Ratings cut Danaher from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, June 29th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $233.52.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.